Journal article
The distinct roles of Negativicoccus and Fusobacterium in proximal- and late-onset colorectal cancer
Gut microbes, Vol.18(1), 2655193
12/31/2026
DOI: 10.1080/19490976.2026.2655193
PMID: 41947036
Abstract
Despite the emerging role of the gut microbiome in colorectal cancer (CRC), its significance in early-onset CRC (EOCRC, < 50 y) versus late-onset CRC (LOCRC) and the molecular differences between proximal and distal CRC remain poorly understood. To circumvent the logistical and patient compliance challenges of stool collection, we explored the utility of anal swabs as a convenient alternative for characterizing gut microbiome signatures in CRC. We profiled the CRC microbiome using anal swabs (
= 76) and stool samples (
= 33) by 16S rRNA sequencing. Diversity indices were compared using Wilcoxon tests, compositional differences assessed by PERMANOVA, and correlations were performed in paired samples. Correlation analysis revealed strong associations between microbial phyla (Bacteroidetes,
= 0.86,
= 4.7 × 10⁻⁶; Firmicutes,
= 0.65,
= 3.4 × 10⁻³; Verrucomicrobiota,
= 0.81,
= 4.8 × 10⁻⁵; and Fusobacterium,
= 0.80,
= 7.3 × 10⁻⁵) and major genera (
,
= 0.88,
= 1.7 × 10⁻⁵;
,
= 0.75,
= 1.5 × 10⁻³;
,
= 0.77,
= 8.5 × 10⁻⁴; and
,
= 0.81,
= 3.3 × 10⁻⁴) across sample types, validating the use of anal swabs. However, Actinobacteriota and
were not correlated, likely reflecting the perianal skin-associated microbiota and underscoring the need for validation against stool or mucosal biopsies. Importantly, anal swabs revealed associations between
and proximal CRC (
= 0.047) and between the Fusobacteriota phylum and LOCRC (
= 0.042), suggesting subtype-specific CRC subtypes. In mechanistic studies, using the mucous-secreting HT-29 MTX cell line, we observed that
was associated with activation the RAS/MAPK pathway, upregulated c-MYC, KRAS, MAPK1, and Cyclin D1 (
< 0.05) and increased proinflammatory cytokines (IL-8) (
< 0.05), thereby increasing cell proliferation. In contrast,
modulates the WNT/β-catenin pathway, increasing
-catenin and AXIN1 (
< 0.05), promoting cell migration (
< 0.05), and extracellular matrix (ECM) remodeling. These findings highlight distinct microbial contributions to CRC pathogenesis, with
influencing proliferation and inflammation, whereas
promotes migration and invasion. Understanding these pathways offers potential for harnessing the gut microbiome's diagnostic and therapeutic power in CRC.
Details
- Title: Subtitle
- The distinct roles of Negativicoccus and Fusobacterium in proximal- and late-onset colorectal cancer
- Creators
- Soham Ali - University of IowaApurva J Patel - University of IowaPeter C Lehman - University of IowaRachel L Fitzjerrells - University of IowaPashtoon Murtaza Kasi - City Of Hope National Medical CenterAshutosh K Mangalam - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Gut microbes, Vol.18(1), 2655193
- DOI
- 10.1080/19490976.2026.2655193
- PMID
- 41947036
- NLM abbreviation
- Gut Microbes
- ISSN
- 1949-0976
- eISSN
- 1949-0984
- Publisher
- Taylor & Francis
- Grant note
- National Institute of Environmental Health Sciences: P30 ES005605 National Institute of Allergy and Infectious Diseases: 1R01AI137075 Philanthropic Gift from P. Heppelmann and M. Wacek Emory D. Warner Medical Student Research National Institutes of Health (NIH): F31DE033564 University of Iowa Division of Internal Medicine and Center of Advancement at the Holden Comprehensive Cancer Center U.S. Department of Veterans Affairs: 1I01CX002212
AKM received funding from the National Institutes of Health/NIAID 1R01AI137075 (AKM), Veteran Affairs Merit Award 1I01CX002212 (AKM), University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH P30 ES005605 (AKM), Philanthropic Gift from P. Heppelmann and M. Wacek to (AKM). PMK received funding from grants and discretionary funds from the University of Iowa Division of Internal Medicine and Center of Advancement at the Holden Comprehensive Cancer Center. SA was supported by an Emory D. Warner Medical Student Research Fellowship. RLF received funding from the National Institutes of Health (NIH), NIH F31DE033564.
- Language
- English
- Date published
- 12/31/2026
- Academic Unit
- Pathology; Iowa Neuroscience Institute; Dental Research
- Record Identifier
- 9985153396502771
Metrics
1 Record Views